INS and diabetes mellitus: One explanation of the apparent protective effect of metformin against cancer in patients with diabetes is therefore that, unlike most other treatments, it reduces rather than increases the levels of insulin, with high insulin levels being responsible for increased cancer incidence in patients on other medications [102].